MIM And Chronimed Merger Completed; BioScrip Begins Operations Today; Trading Begins Today Under 'BIOS'; Combined Company To Be One Of Largest Specialty Pharmacies In U.S.
Published: Mar 14, 2005
ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--March 14, 2005--BioScrip, Inc. (NASDAQ: BIOS), a comprehensive specialty pharmacy company created by the merger of MIM Corporation and Chronimed Inc., today marked the historic launch of its combined operations. Shareholders approved the merger at special meetings held on March 9, 2005. The merger became effective on March 12, 2005. The Company was renamed "BioScrip" and begins trading today on the NASDAQ Stock Market under the ticker symbol "BIOS". Richard H. Friedman, BioScrip's Executive Chairman, stated, "We have executed on our vision of creating a comprehensive specialty pharmacy company with an expansive national footprint, increasing local and national access to patients, providers and payors. This merger is a great strategic fit. Today, BioScrip is better prepared to address the challenges of a constantly changing healthcare environment."